作为质母细胞瘤衰老和预后的调节剂的PSMA5

Jiahao Yao1, Hongyu Zhang1, Qiang Gu1

  • 1Department of Neurosurgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.

BMC cancer
|July 2, 2025
PubMed
概括

一个新的质母细胞瘤 (GBM) 风险模型突出了PSMA5的重点.